Developing market access strategy
In the recent years the pharmaceutical market has undergone some major changes, especially with respect to regulations and funding. These changes had an impact on market access strategies of many industry players. In the same manner, the ever-growing importance of payers changes the approaches to pricing and market access: health technology assessment now plays a crucial role in the launch of the novel pharmaceuticals.
New realities urge the drug manufacturers to tailor their strategies to the specifics of each region and territory. This, in turn, requires in-depth market expertise of the local environment, including regulatory and financial aspects and establishing effective communication with local health authorities.
Aston Group with its resources and expertise helps customers to design and review their market access and pricing strategies through:
- HTA analysis in collaboration with the leading clinical centers
- Pharmacoeconomic studies based on patient registry data in more than twenty therapeutic areas
- Regional cross analysis of sales in reimbursement segment - Aston 360
- Pricing studies
- Developing market access strategies on federal and regional levels
- Monitoring changes in healthcare industry - PharmCompass Russia and PharmCompass Regions
|
|
||
 |
 |
 |
Development of marketing strategy
